China Shineway Pharma schedules board meeting on interim results, dividend decisionPUBT·Aug 17 at 03:32 AM02877-1.19%
Severed Apple Ties and a Dividend Surge: How Hong Kong's Fringe Stocks Are Navigating 2026Global Report·Jul 29 at 04:18 AM080030.00%03816+7.24%
Macro Signals Testing the Hong Kong Market: Pricing From Real Estate to CyclicalsGlobal Report·Jul 21 at 04:13 AM02877-1.19%09696-4.87%
The Island of Misfit Stocks: From Elon's Giga Press to Real Estate DefaultsGlobal Report·Jul 17 at 04:12 AM02877-1.19%016850.00%
Kingsoft Gets the Boot While Instant Noodles and Infrastructure Quietly Print CashGlobal Report·Jul 7 at 05:38 AM03888+3.04%03996-0.47%
China Shineway Pharma Sets 2026 AGM to Approve Results and Share Issuance MandateTip Ranks·Apr 23 at 05:12 AM02877-1.19%
China Shineway Pharmaceutical Declares First Interim Dividend for Fiscal 2026Tip Ranks·Mar 26 at 11:55 PM159929+1.90%512290+2.03%
Shineway Profit Rises Despite Revenue Slump as TCM Sector ResetsTip Ranks·Mar 26 at 11:09 PM512290+2.03%159992+2.12%
China Shineway Pharmaceutical Group Limited (2877) Receives a Buy from Guoyuan Securities (HK)Tip Ranks·Dec 18, 2025 at 11:05 PM02877-1.19%
Zhitong Hong Kong Stock Investment Diary | September 9Zhitong·Sep 8, 2025 at 11:01 AM01209+0.76%601857+0.18%
SHINEWAY PHARM released its interim results, with a profit of 615 million yuan, a year-on-year decrease of 1.89%Zhitong·Aug 26, 2025 at 11:07 PM02877-1.19%
Zhitong Hong Kong Stock Investment Log | August 27Zhitong·Aug 26, 2025 at 11:01 AM06911-5.45%00248-1.85%
SHINEWAY PHARM: Wang Guihua has been appointed as a member of the Nomination CommitteeZhitong·Jun 9, 2025 at 11:22 PM02877-1.19%
